IE
SGRY icon

Israel Englander’s Surgery Partners SGRY Stock Holding History

Israel Englander’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-225,000
Closed -$2.68M – 6347
2026
Q1 		$2.68M Buy
225,000
+24,100
+12% +$346K ﹤0.01% 3586
2025
Q4 		$3.1M Buy
+200,900
New +$3.69M ﹤0.01% 3518
2024
Q4 		– Sell
-20,000
Closed -$645K – 6416
2024
Q3 		$645K Sell
20,000
-80,000
-80% -$2.36M ﹤0.01% 4621
2024
Q2 		$2.38M Buy
+100,000
New +$2.57M ﹤0.01% 3383
2023
Q3 		– Sell
-50,000
Closed -$2.25M – 6511
2023
Q2 		$2.25M Buy
+50,000
New +$1.91M ﹤0.01% 3372
2023
Q1 		– Sell
-75,000
Closed -$2.09M – 6804
2022
Q4 		$2.09M Buy
+75,000
New +$1.99M ﹤0.01% 3527
2019
Q3 		– Sell
-100,000
Closed -$814K – 4512
2019
Q2 		$814K Buy
+100,000
New +$997K ﹤0.01% 2927

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's SGRY Position: Q2 2026 in Review

Israel Englander sold out of Surgery Partners (SGRY) in Q2 2026, closing a stake of 423,840 shares — an estimated $5.05M sold.

Israel Englander first reported a position in SGRY in Q4 2015 and held it in 31 quarters. The position peaked at $34.9M in Q3 2021. 186 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Israel Englander reported no remaining Surgery Partners position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 423,840 Surgery Partners shares in Q2 2026, an estimated $5.05M.
  • Israel Englander first reported a position in Surgery Partners in Q4 2015 and held it in 31 quarters.
  • Israel Englander's Surgery Partners position peaked at $34.9M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.